Latest News about BNTX
Recent news which mentions BNTX
2 Reasons Why Pfizer Might Crush Moderna in the mRNA Market. And 1 Reason Why Moderna May Stay Ahead.
February 17, 2022
From Motley Fool
U.S. excess death toll has climbed above one million during the pandemic; ‘We’ve never seen anything like it,’ says CDC official
February 16, 2022
From MarketWatch
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
From Benzinga
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
From InvestorPlace
What to Expect From Pfizer and BioNTech's Next Meeting With the FDA
February 15, 2022
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
February 15, 2022
From Motley Fool
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
From Benzinga
Why Pfizer Shares Are Trading Lower Today
February 14, 2022
From Benzinga
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Sliding Today
February 14, 2022
From Motley Fool
Why BioNTech Shares Are Falling Today
February 14, 2022
From Benzinga
From MarketWatch
FDA Postpones Adcomm For Pfizer's COVID-19 Vaccine For Youngest Kids
February 14, 2022
From Benzinga
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
February 12, 2022
From Motley Fool
From Benzinga
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
From InvestorPlace
US Plans COVID-19 Vaccine Roll Out For Kids Under 5 Years This Month
February 10, 2022
From Benzinga
CDC directs vaccine makers to prep for shots for children below 5 by Feb. 21, as FDA advisory meeting looms
February 10, 2022
From MarketWatch
Down 52% In 3 Months, Is Moderna Stock a Bargain Buy?
February 09, 2022
From Motley Fool
Pfizer expects a record $100 billion in revenue this year, thanks to COVID vaccines and treatments
February 08, 2022
From MarketWatch
From Benzinga
Pregnant women who contract COVID-19 are more likely to develop serious complications
February 07, 2022
From MarketWatch
From Motley Fool
Is it Too Late to Buy Vaccine Stocks?
February 07, 2022
From Motley Fool
From Benzinga
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
February 04, 2022
From Benzinga
6 Stocks That Could Soar If New Coronavirus Variants Emerge
February 04, 2022
From Motley Fool
7 Hot Stocks That Can Win in Either a Bull or Bear Market
February 04, 2022
From InvestorPlace
Is It Time to Buy January's 5 Worst-Performing Nasdaq Stocks?
February 03, 2022
From Motley Fool
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.